相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。MMP-9 Upregulation is Attenuated by the Monoclonal TLR2 Antagonist T2.5 After Oxygen-Glucose Deprivation and Reoxygenation in Rat Brain Microvascular Endothelial Cells
Hongyan Zhu et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2019)
Baicalin Attenuates Blood-Brain Barrier Disruption and Hemorrhagic Transformation and Improves Neurological Outcome in Ischemic Stroke Rats with Delayed t-PA Treatment: Involvement of ONOO--MMP-9 Pathway
Hansen Chen et al.
TRANSLATIONAL STROKE RESEARCH (2018)
Targeting RNS/caveolin-1/MMP signaling cascades to protect against cerebral ischemia-reperfusion injuries: potential application for drug discovery
Han-sen Chen et al.
ACTA PHARMACOLOGICA SINICA (2018)
Free Radical Damage in Ischemia-Reperfusion Injury: An Obstacle in Acute Ischemic Stroke after Revascularization Therapy
Ming-Shuo Sun et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2018)
Cell permeable HMGB1-binding heptamer peptide ameliorates neurovascular complications associated with thrombolytic therapy in rats with transient ischemic stroke
Miaodan Li et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Potential molecular targets of peroxynitrite in mediating blood-brain barrier damage and haemorrhagic transformation in acute ischaemic stroke with delayed tissue plasminogen activator treatment
Hansen Chen et al.
FREE RADICAL RESEARCH (2018)
One-Compound-Multi-Target: Combination Prospect of Natural Compounds with Thrombolytic Therapy in Acute Ischemic Stroke
Han-Sen Chen et al.
CURRENT NEUROPHARMACOLOGY (2017)
Adjunctive Therapy Approaches for Ischemic Stroke: Innovations to Expand Time Window of Treatment
Talia Knecht et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Therapeutic Strategies to Attenuate Hemorrhagic Transformation After Tissue Plasminogen Activator Treatment for Acute Ischemic Stroke
Masato Kanazawa et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2017)
HMGB1-RAGE pathway drives peroxynitrite signaling-induced IBD-like inflammation in murine nonalcoholic fatty liver disease
Varun Chandrashekaran et al.
REDOX BIOLOGY (2017)
Pharmacological Management Options to Prevent and Reduce Ischemic Hemorrhagic Transformation
Wing Mann Ho et al.
CURRENT DRUG TARGETS (2017)
Inhibiting HMGB1 Reduces Cerebral Ischemia Reperfusion Injury in Diabetic Mice
Chong Wang et al.
INFLAMMATION (2016)
Glycyrrhizin protects against focal cerebral ischemia via inhibition of T cell activity and HMGB1-mediated mechanisms
Xiaoxing Xiong et al.
JOURNAL OF NEUROINFLAMMATION (2016)
A rationally designed rhodamine-based fluorescent probe for molecular imaging of peroxynitrite in live cells and tissues
Tao Peng et al.
CHEMICAL SCIENCE (2016)
Peroxynitrite Decomposition Catalyst Reduces Delayed Thrombolysis-induced Hemorrhagic Transformation in Ischemia-reperfused Rat Brains
Han-Sen Chen et al.
CNS NEUROSCIENCE & THERAPEUTICS (2015)
Fluorescent Probe HKSOX-1 for Imaging and Detection of Endogenous Superoxide in Live Cells and In Vivo
Jun Jacob Hu et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2015)
Glycyrrhizin protects brain against ischemia-reperfusion injury in mice through HMGB1-TLR4-IL-17A signaling pathway
Jiancheng Zhang et al.
BRAIN RESEARCH (2014)
Hemorrhagic transformation after ischemic stroke in animals and humans
Glen C. Jickling et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2014)
Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials
Jonathan Emberson et al.
LANCET (2014)
Protective Effect of Glycyrrhizin, a Direct HMGB1 Inhibitor, on Focal Cerebral Ischemia/Reperfusion-Induced Inflammation, Oxidative Stress, and Apoptosis in Rats
Gu Gong et al.
PLOS ONE (2014)
An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies
Domenica Musumeci et al.
PHARMACOLOGY & THERAPEUTICS (2014)
Recommendations for Preclinical Research in Hemorrhagic Transformation
Susan C. Fagan et al.
TRANSLATIONAL STROKE RESEARCH (2013)
Glycyrrhizic acid affords robust neuroprotection in the postischemic brain via anti-inflammatory effect by inhibiting HMGB1 phosphorylation and secretion
Seung-Woo Kim et al.
NEUROBIOLOGY OF DISEASE (2012)
Intranasal delivery of HMGB1-binding heptamer peptide confers a robust neuroprotection in the postischemic brain
Il-Doo Kim et al.
NEUROSCIENCE LETTERS (2012)
The neurovascular unit and combination treatment strategies for stroke
Li Zhang et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2012)
Peroxynitrite induces HMGB1 release by cardiac cells in vitro and HMGB1 upregulation in the infarcted myocardium in vivo
Noureddine Loukili et al.
CARDIOVASCULAR RESEARCH (2011)
Anti-high Mobility Group Box-1 Monoclonal Antibody Protects the Blood-Brain Barrier From Ischemia-Induced Disruption in Rats
Jiyong Zhang et al.
STROKE (2011)
Thrombolysis for Cerebral Ischemia
Jennifer E. Fugate et al.
Frontiers in Neurology (2011)
High-Mobility Group Box 1 Promotes Metalloproteinase-9 Upregulation Through Toll-Like Receptor 4 After Cerebral Ischemia
Jianhua Qiu et al.
STROKE (2010)
Normobaric Hyperoxia Reduces the Neurovascular Complications Associated With Delayed Tissue Plasminogen Activator Treatment in a Rat Model of Focal Cerebral Ischemia
Wenlan Liu et al.
STROKE (2009)
Normobaric hyperoxia inhibits NADPH oxidase-mediated matrix metalloproteinase-9 induction in cerebral microvessels in experimental stroke
Wenlan Liu et al.
JOURNAL OF NEUROCHEMISTRY (2008)
The HMGB1 Receptor RAGE Mediates Ischemic Brain Damage
Sajjad Muhammad et al.
JOURNAL OF NEUROSCIENCE (2008)
Induction and subcellular localization of high-mobility group box-1 (HMGB1) in the postischemic rat brain
Jung-Bin Kim et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2008)
Early release of HMGB-1 from neurons after the onset of brain ischemia
Jianhua Qiu et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2008)
Anti-high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats
Keyue Liu et al.
FASEB JOURNAL (2007)
Glycyrrhizin binds to high-mobility group box 1 protein and inhibits its cytokine activities
Luca Mollica et al.
CHEMISTRY & BIOLOGY (2007)
HMGB1, a novel cytokine-like mediator linking acute neuronal death and delayed neuroinflammation in the postischemic brain
Jung-Bin Kim et al.
JOURNAL OF NEUROSCIENCE (2006)
Tissue plasminogen activator promotes matrix metalloproteinase-9 upregulation after focal cerebral ischemia
K Tsuji et al.
STROKE (2005)
Reperfusion-induced oxidative/nitrative injury to neurovascular unit after focal cerebral ischemia
Y Gürsoy-Özdemir et al.
STROKE (2004)
Closure of the blood-brain barrier by matrix metalloproteinase inhibition reduces rtPA-mediated mortality in cerebral ischemia with delayed reperfusion
T Pfefferkorn et al.
STROKE (2003)
Peroxynitrite-induced cytotoxicity:: mechanism and opportunities for intervention
L Virág et al.
TOXICOLOGY LETTERS (2003)
Concurrent formation of peroxynitrite nitric oxide synthase in the brain with the expression of inducible during middle cerebral artery occlusion and reperfusion in rats
M Suzuki et al.
BRAIN RESEARCH (2002)
Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats
T Sumii et al.
STROKE (2002)
Matrix metalloproteinase inhibition prevents oxidative stress-associated blood-brain barrier disruption after transient focal cerebral ischemia
Y Gasche et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2001)
Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats
JL Chen et al.
STROKE (2001)
Metalloproteinase inhibition reduces thrombolytic (tissue plasminogen activator)-induced hemorrhage after thromboembolic stroke
PA Lapchak et al.
STROKE (2000)
分享论文
